A comprehensive view of Bristol-Myers Squibb Co.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Bristol Myers reports Q1 US revenues up 7% year-over-year to US$8.5B primarily due to Eliquis, Reblozyl and Opdualag; International revenues remain flat at US$3.4B primarily due to lower average net selling prices
Published: April 25, 2024 by Business Wire
Bristol Myers reports Q1 loss of US$11.91B on revenue of US$11.87B
Published: April 25, 2024 by Associated Press
BRISTOL MYERS SQUIBB CO - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Published: April 25, 2024 by SEC Edgar Filings
BRISTOL MYERS SQUIBB CO - (8-K) - Disclosing Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
Published: April 25, 2024 by SEC Edgar Filings
Bristol Myers Squibb reports first quarter financial results for 2024
Published: April 25, 2024 by Bristol-Myers Squibb Co.

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count